Serum carcinoembryonic antigen (CEA) is the most widely used tumor marker for colorectal malignancies but few studies have examined the clinical utility of CEA in patients with rectal cancer.
Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...
A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.” ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
In combination with established tumor markers, EDTA-plasma M2-PK is a useful ... M2-PK in EDTA-plasma even proves superiority as compared with CEA. Fecal Tumor M2-PK testing resembles a good ...
Hosted on MSN16d
Tracking cfDNA levels may help better evaluate surgery colorectal cancer effectivenessand patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to ...
Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, intense surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback